Surveillance for Lyme disease in Canada: 2009-2015
- PMID: 29770045
- PMCID: PMC5764744
- DOI: 10.14745/ccdr.v43i10a01
Surveillance for Lyme disease in Canada: 2009-2015
Abstract
Objective: To summarize seven years of surveillance data for Lyme disease cases reported in Canada from 2009 to 2015.
Methods: We describe the incidence over time, seasonal and geographic distribution, demographic and clinical characteristics of reported Lyme disease cases. Logistic regression was used to explore differences between age groups, sex and year to better understand potential demographic risk factors for the occurrence of Lyme disease.
Results: The number of reported Lyme disease cases increased more than six-fold, from 144 in 2009 to 917 in 2015, mainly due to an increase in infections acquired in Canada. Most locally acquired cases were reported between May and November. An increase in incidence of Lyme disease was observed in provinces from Manitoba eastwards. This is consistent with our knowledge of range expansion of the tick vectors in this region. In the western provinces the incidence has remained low and stable. All cases reported by Alberta, Saskatchewan and Newfoundland and Labrador were acquired outside of the province, either elsewhere in Canada or abroad. There was a bimodal distribution for Lyme disease by age with peaks at 5-9 and 45-74 years of age. The most common presenting symptom was a single erythema migrans rash (74.2%) and arthritis (35.7%). Variations in the frequency of reported clinical manifestations were observed among age groups and years of study.
Conclusion: Lyme disease incidence continues to increase in Canada as does the geographic range of ticks that carry the Lyme disease bacteria. Ongoing surveillance, preventive strategies as well as early disease recognition and treatment will continue to minimize the impact of Lyme disease in Canada.
Conflict of interest statement
Conflict of interest: None.
Figures
References
-
- Ogden NH, Koffi KJ, Pelcat Y, Lindsay LR. Environmental risk from Lyme disease in central and eastern Canada: a summary of recent surveillance information. Can Commun Dis Rep 2014;40(5):74–82. Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/14vol40/dr-rm40-05/assets/... - PMC - PubMed
-
- Hatchette TF, Davis I, Johnston BL. Lyme disease: clinical diagnosis and treatment. Can Commun Dis Rep 2014;40(11):194–208. Available from: https://www.canada.ca/en/public-health/services/reports-publications/can... - PMC - PubMed
-
- Bacon RM, Kugeler KJ, Mead PS; Centers for Disease Control and Prevention (CDC). Surveillance for Lyme disease--United States, 1992-2006. MMWR Surveill Summ 2008. Oct;57(10 SS-10):1–9. - PubMed
-
- Public Health Agency of Canada. Surveillance of Lyme disease. Ottawa: Public Health Agency of Canada; 2017. https://www.canada.ca/en/public-health/services/diseases/lyme-disease/su... [Accessed 2017 Apr 13].
